Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Metra

Showing results (181-190 of 1,328) with videos related to

Pageof 133
Sort By:
Journal of Cardiovascular Medicine (Hagerstown, Md.)|August 10, 2019
New drugs for the treatment of chronic heart failure with a reduced ejection fraction: What the future may holdEdoardo Sciatti, Lucia Dallapellegrina, Marco Metra, et al.
European Heart Journal|July 24, 2020
Atrial fibrillation in the COVID-19 era: simple bystander or marker of increased risk?Riccardo M Inciardi, Marianna Adamo, Laura Lupi, et al.
European Heart Journal Supplements : Journal of the European Society of Cardiology|February 21, 2025
Towards a phenotype profiling of the patients with heart failure and preserved ejection fractionGiovanni Battista Bonfioli, Matteo Pagnesi, Leonardo Calò, et al.
Heart Failure Reviews|October 19, 2024
GLP-1 receptor agonists as promising anti-inflammatory agents in heart failure with preserved ejection fractionGiovanni Battista Bonfioli, Luca Rodella, Marco Metra, et al.
Heart International|October 7, 2011
Non-compaction of the ventricular myocardiumEnrico Vizzardi, Savina Nodari, Marco Metra, et al.
Heart International|October 7, 2011
Endocannabinoids and cardiovascular prevention: real progress?Savina Nodari, Alessandra Manerba, Marco Metra, et al.
European Journal of Heart Failure|January 9, 2021
Renin-angiotensin-aldosterone inhibitors and COVID-19: nearing the end of a media-fuelled controversyDaniela Tomasoni, Mark C Petrie, Marianna Adamo, et al.
ESC Heart Failure|October 16, 2024
Reframing the role of glucagon-like peptide 1 receptor agonists in cardiovascular medicineRiccardo M Inciardi, Alvin Chandra, Ambarish Pandey, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|July 6, 2023
Cardiovascular imaging updates and future perspectivesGiada Colombo, Matteo Cameli, Marco Metra, et al.
European Journal of Heart Failure|May 26, 2017
Integrating electronic health records into the study of heart failure: promises and pitfallsMuthiah Vaduganathan, Ravi B Patel, Javed Butler, et al.
Pageof 133

Showing results (181-190 of 1,328) with videos related to

Sort By:
Pageof 133
Journal of Cardiovascular Medicine (Hagerstown, Md.)|August 10, 2019
New drugs for the treatment of chronic heart failure with a reduced ejection fraction: What the future may holdEdoardo Sciatti, Lucia Dallapellegrina, Marco Metra, et al.
European Heart Journal|July 24, 2020
Atrial fibrillation in the COVID-19 era: simple bystander or marker of increased risk?Riccardo M Inciardi, Marianna Adamo, Laura Lupi, et al.
European Heart Journal Supplements : Journal of the European Society of Cardiology|February 21, 2025
Towards a phenotype profiling of the patients with heart failure and preserved ejection fractionGiovanni Battista Bonfioli, Matteo Pagnesi, Leonardo Calò, et al.
Heart Failure Reviews|October 19, 2024
GLP-1 receptor agonists as promising anti-inflammatory agents in heart failure with preserved ejection fractionGiovanni Battista Bonfioli, Luca Rodella, Marco Metra, et al.
Heart International|October 7, 2011
Non-compaction of the ventricular myocardiumEnrico Vizzardi, Savina Nodari, Marco Metra, et al.
Heart International|October 7, 2011
Endocannabinoids and cardiovascular prevention: real progress?Savina Nodari, Alessandra Manerba, Marco Metra, et al.
European Journal of Heart Failure|January 9, 2021
Renin-angiotensin-aldosterone inhibitors and COVID-19: nearing the end of a media-fuelled controversyDaniela Tomasoni, Mark C Petrie, Marianna Adamo, et al.
ESC Heart Failure|October 16, 2024
Reframing the role of glucagon-like peptide 1 receptor agonists in cardiovascular medicineRiccardo M Inciardi, Alvin Chandra, Ambarish Pandey, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|July 6, 2023
Cardiovascular imaging updates and future perspectivesGiada Colombo, Matteo Cameli, Marco Metra, et al.
European Journal of Heart Failure|May 26, 2017
Integrating electronic health records into the study of heart failure: promises and pitfallsMuthiah Vaduganathan, Ravi B Patel, Javed Butler, et al.
Pageof 133